Sleep, hypnotics and chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 102, Issue 6, 2008, Pages 801-814

  Stege, Gerben ^a   Vos, Petra J E ^a   van den Elshout, Frank J J ^a   Richard Dekhuijzen, P N ^b   van de Ven, Marjo J T ^a   Heijdra, Yvonne F ^b  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Benzodiazepines; Breathing; Chronic obstructive; Hypnotics; Non benzodiazepine benzodiazepine receptor agonist; Pulmonary disease

Indexed keywords

ALPIDEM; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BROTIZOLAM; CODEINE PHOSPHATE; CORTICOSTEROID; DIAZEPAM; ESTAZOLAM; ESZOPICLONE; FLUNITRAZEPAM; FLURAZEPAM; GLUTETHIMIDE; HYPNOTIC SEDATIVE AGENT; IPRATROPIUM BROMIDE; LORAZEPAM; MELATONIN RECEPTOR; METHYLXANTHINE; MIDAZOLAM; NITRAZEPAM; PREDNISONE; SALBUTAMOL; TEMAZEPAM; TIOTROPIUM BROMIDE; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ABSENCE OF SIDE EFFECTS; ANXIETY; AROUSAL; ARTERIAL OXYGEN SATURATION; BREATHING MUSCLE; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COUGHING; DIZZINESS; DROWSINESS; DRUG BINDING; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DYSPNEA; ESOPHAGUS PRESSURE; FATIGUE; FEEDBACK SYSTEM; HUMAN; HYPERCAPNIA; HYPERICUM PERFORATUM; HYPOXEMIA; INSOMNIA; LUNG MINUTE VOLUME; MEMORY DISORDER; MENTAL DISEASE; MUCUS SECRETION; MUSCLE HYPOTONIA; PATIENT EDUCATION; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; REBOUND; RELAXATION TRAINING; REM SLEEP; REVIEW; SIDE EFFECT; SLEEP DISORDERED BREATHING; WITHDRAWAL SYNDROME;

HUMANS; HYPNOTICS AND SEDATIVES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; SLEEP; SLEEP DISORDERS;

EID: 43049097799     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.12.026     Document Type: Review

References (149)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive summary: global strategy for the diagnosis, management, and prevention of COPD, 〈www.goldcopd.com〉 [accessed March 2007]. Date last updated: November 2006.
2. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
3. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., and Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147 (1993) 1151-1156
4. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
5. Jagoe R.T., and Engelen M.P. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl 46 (2003) 52s-63s
6. Vonk-Noordegraaf A., Marcus J.T., Holverda S., Roseboom B., and Postmus P.E. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 127 (2005) 1898-1903
7. Weitzenblum E. Chronic cor pulmonale. Heart 89 (2003) 225-230
8. Barbera J.A., Peinado V.I., and Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 892-905
9. Kessler R., Faller M., Weitzenblum E., et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 164 (2001) 219-224
10. Kinsman R.A., Yaroush R.A., Fernandez E., Dirks J.F., Schocket M., and Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest 83 (1983) 755-761
11. Breslin E., van der Schans C., Breukink S., et al. Perception of fatigue and quality of life in patients with COPD. Chest 114 (1998) 958-964
12. Klink M.E., Dodge R., and Quan S.F. The relation of sleep complaints to respiratory symptoms in a general population. Chest 105 (1994) 151-154
13. Cormick W., Olson L.G., Hensley M.J., and Saunders N.A. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 41 (1986) 846-854
14. Leitch A.G., Clancy L.J., Leggett R.J., Tweeddale P., Dawson P., and Evans J.I. Arterial blood gas tensions, hydrogen ion, and electroencephalogram during sleep in patients with chronic ventilatory failure. Thorax 31 (1976) 730-735
15. Fleetham J., West P., Mezon B., Conway W., Roth T., and Kryger M. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis 126 (1982) 429-433
16. Brezinova V., Catterall J.R., Douglas N.J., Calverley P.M., and Flenley D.C. Night sleep of patients with chronic ventilatory failure and age matched controls: number and duration of the EEG episodes of intervening wakefulness and drowsiness. Sleep 5 (1982) 123-130
17. Fletcher E.C., Gray B.A., and Levin D.C. Nonapneic mechanisms of arterial oxygen desaturation during rapid-eye-movement sleep. J Appl Physiol 54 (1983) 632-639
18. Gleeson K., Zwillich C.W., and White D.P. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 142 (1990) 295-300
19. Gillin J.C., Jacobs L.S., Fram D.H., and Snyder F. Acute effect of a glucocorticoid on normal human sleep. Nature 237 (1972) 398-399
20. Guilleminault C., and Silvestri R. Aging, drugs and sleep. Neurobiol Aging 3 (1982) 379-386
21. Veale D., Cooper B.G., Griffiths C.J., Corris P.A., and Gibson G.J. The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease. Respir Med 88 (1994) 121-124
22. Martin R.J., Bartelson B.L., Smith P., et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 115 (1999) 1338-1345
23. McNicholas W.T., Calverley P.M., Lee A., and Edwards J.C. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 23 (2004) 825-831
24. Mulloy E., and McNicholas W.T. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 148 (1993) 1030-1036
25. Phillips B.A., Cooper K.R., and Burke T.V. The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest 91 (1987) 29-32
26. Buysse D.J., Ancoli-Israel S., Edinger J.D., Lichstein K.L., and Morin C.M. Recommendations for a standard research assessment of insomnia. Sleep 29 (2006) 1155-1173
27. National Heart Lung and Blood Institute Working Group on Insomnia. Insomnia: assessment and management in primary care. Am Fam Physician 59 (1999) 3029-3038
28. Roth T. Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry 66 Suppl. 9 (2005) 10-13
29. Weissman M.M., Greenwald S., Nino-Murcia G., and Dement W.C. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19 (1997) 245-250
30. Kapur V.K., Redline S., Nieto F.J., Young T.B., Newman A.B., and Henderson J.A. The relationship between chronically disrupted sleep and healthcare use. Sleep 25 (2002) 289-296
31. Chevalier H., Los F., Boichut D., et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol 13 (1999) S21-S24
32. Zammit G.K., Weiner J., Damato N., Sillup G.P., and McMillan C.A. Quality of life in people with insomnia. Sleep 22 Suppl. 2 (1999) S379-S385
33. Roth T., and Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone 5 (2003) 5-15
34. Benca R.M. Consequences of insomnia and its therapies. J Clin Psychiatry 62 Suppl. 10 (2001) 33-38
35. Klink M., and Quan S.F. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 91 (1987) 540-546
36. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
37. Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., and Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep 30 (2007) 213-218
38. Alattar M., Harrington J.J., Mitchell C.M., and Sloane P. Sleep problems in primary care: a North Carolina Family Practice Research Network (NC-FP-RN) study. J Am Board Fam Med 20 (2007) 365-374
39. Douglas N.J., and Flenley D.C. Breathing during sleep in patients with obstructive lung disease. Am Rev Respir Dis 141 (1990) 1055-1070
40. Hudgel D.W., Martin R.J., Johnson B., and Hill P. Mechanics of the respiratory system and breathing pattern during sleep in normal humans. J Appl Physiol 56 (1984) 133-137
41. Lopes J.M., Tabachnik E., Muller N.L., Levison H., and Bryan A.C. Total airway resistance and respiratory muscle activity during sleep. J Appl Physiol 54 (1983) 773-777
42. Hudgel D.W., and Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol 57 (1984) 1319-1322
43. McNicholas W.T. Impact of sleep in COPD. Chest 117 (2000) 48S-53S
44. McNicholas W.T. Impact of sleep on respiratory muscle function. Monaldi Arch Chest Dis 57 (2002) 277-280
45. Douglas N.J., White D.P., Weil J.V., et al. Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis 125 (1982) 286-289
46. Douglas N.J., White D.P., Pickett C.K., Weil J.V., and Zwillich C.W. Respiration during sleep in normal man. Thorax 37 (1982) 840-844
47. Hetzel M.R., and Clark T.J. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 35 (1980) 732-738
48. Postma D.S., Koeter G.H., Keyzer J.J., and Meurs H. Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction. J Allergy Clin Immunol 77 (1986) 471-477
49. Hudgel D.W. Differential activation of respiratory muscles during wakefulness and sleep. Prog Clin Biol Res 345 (1990) 233-239
50. Wiegand L., Zwillich C.W., Wiegand D., and White D.P. Changes in upper airway muscle activation and ventilation during phasic REM sleep in normal men. J Appl Physiol 71 (1991) 488-497
51. Beam W.R., Weiner D.E., and Martin R.J. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 146 (1992) 1524-1530
52. Ballard R.D., Irvin C.G., Martin R.J., Pak J., Pandey R., and White D.P. Influence of sleep on lung volume in asthmatic patients and normal subjects. J Appl Physiol 68 (1990) 2034-2041
53. White J.E., Drinnan M.J., Smithson A.J., Griffiths C.J., and Gibson G.J. Respiratory muscle activity during rapid eye movement (REM) sleep in patients with chronic obstructive pulmonary disease. Thorax 50 (1995) 376-382
54. Tusiewicz K., Moldofsky H., Bryan A.C., and Bryan M.H. Mechanics of the rib cage and diaphragm during sleep. J Appl Physiol 43 (1977) 600-602
55. Johnson M.W., and Remmers J.E. Accessory muscle activity during sleep in chronic obstructive pulmonary disease. J Appl Physiol 57 (1984) 1011-1017
56. Calverley P.M. Impact of sleep on respiration. Eur Resp Monogr 10 (1998) 9-27
57. O'Donoghue F.J., Catcheside P.G., Eckert D.J., and McEvoy R.D. Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease. J Physiol 559 (2004) 663-673
58. Stradling J.R., Chadwick G.A., and Frew A.J. Changes in ventilation and its components in normal subjects during sleep. Thorax 40 (1985) 364-370
59. Becker H.F., Piper A.J., Flynn W.E., et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 159 (1999) 112-118
60. Ballard R.D., Clover C.W., and Suh B.Y. Influence of sleep on respiratory function in emphysema. Am J Respir Crit Care Med 151 (1995) 945-951
61. Calverley P.M., Lee A., Towse L., van Noord J., Witek T.J., and Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 58 (2003) 855-860
62. Dawkins K.D., and Muers M.F. Diurnal variation in airflow obstruction in chronic bronchitis. Thorax 36 (1981) 618-621
63. Postma D.S., Koeter G.H., vd Mark T.W., Reig R.P., and Sluiter H.J. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 87 (1985) 653-657
64. Mulloy E., and McNicholas W.T. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 109 (1996) 387-394
65. Heijdra Y.F., Dekhuijzen P.N., van Herwaarden C.L., and Folgering H.T. Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease. Thorax 50 (1995) 610-612
66. Koo K.W., Sax D.S., and Snider G.L. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 58 (1975) 663-670
67. Coccagna G., and Lugaresi E. Arterial blood gases and pulmonary and systemic arterial pressure during sleep in chronic obstructive pulmonary disease. Sleep 1 (1978) 117-124
68. Douglas N.J., Calverley P.M., Leggett R.J., Brash H.M., Flenley D.C., and Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1 (1979) 1-4
69. Wynne J.W., Block A.J., Hemenway J., Hunt L.A., and Flick M.R. Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med 66 (1979) 573-579
70. Vos P.J.E., Folgering F.T., and van Herwaarden C.L. Prevalence and severity of nocturnal oxygen desaturations in COPD patients. Sleep Health Risk 4 (1991) 246-251
71. Tirlapur V.G., and Mir M.A. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med 306 (1982) 125-130
72. Shepard Jr. J.W., Schweitzer P.K., Keller C.A., Chun D.S., and Dolan G.F. Myocardial stress. Exercise versus sleep in patients with COPD. Chest 86 (1984) 366-374
73. Boysen P.G., Block A.J., Wynne J.W., Hunt L.A., and Flick M.R. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 76 (1979) 536-542
74. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one. Am J Respir Crit Care Med 150 (1994) 833-852
75. McNicholas W.T., and Fitzgerald M.X. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) 289 (1984) 878
76. Sanders M.H., Newman A.B., Haggerty C.L., et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 167 (2003) 7-14
77. Weitzenblum E., Krieger J., Apprill M., et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138 (1988) 345-349
78. Whyte K.F., and Douglas N.J. Peripheral edema in the sleep apnea/hypopnea syndrome. Sleep 14 (1991) 354-356
79. Bradley T.D., Rutherford R., Lue F., et al. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 134 (1986) 920-924
80. Sridhar G.R., and Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract 23 (1994) 183-186
81. Prejbisz A., Kabat M., Januszewicz A., et al. Characterization of insomnia in patients with essential hypertension. Blood Press 15 (2006) 213-219
82. Pagel J.F. Medications and their effects on sleep. Prim Care 32 (2005) 491-509
83. Bootzin R.R., and Perlis M.L. Nonpharmacologic treatments of insomnia. J Clin Psychiatry 53 Suppl. (1992) 37-41
84. Jacobs G.D., Pace-Schott E.F., Stickgold R., and Otto M.W. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 164 (2004) 1888-1896
85. Morin C.M., Hauri P.J., Espie C.A., Spielman A.J., Buysse D.J., and Bootzin R.R. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 22 (1999) 1134-1156
86. Smith M.T., Perlis M.L., Park A., et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159 (2002) 5-11
87. Becker P.M. Pharmacologic and nonpharmacologic treatments of insomnia. Neurol Clin 23 (2005) 1149-1163
88. Sateia M.J., and Nowell P.D. Insomnia. Lancet 364 (2004) 1959-1973
89. Benca R.M. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 56 (2005) 332-343
90. Calverley P.M., Brezinova V., Douglas N.J., Catterall J.R., and Flenley D.C. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 126 (1982) 206-210
91. Goldstein R.S., Ramcharan V., Bowes G., McNicholas W.T., Bradley D., and Phillipson E.A. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med 310 (1984) 425-429
92. McKeon J.L., Murree-Allen K., and Saunders N.A. Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease. Thorax 44 (1989) 184-188
93. Kaplan J., Fredrickson P.A., Renaux S.A., and O'Brien P.C. Theophylline effect on sleep in normal subjects. Chest 103 (1993) 193-195
94. Roehrs T., Merlotti L., Halpin D., Rosenthal L., and Roth T. Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness. Chest 108 (1995) 382-387
95. Brander P.E., and Salmi T. Nocturnal oxygen saturation and sleep quality in patients with advanced chronic obstructive pulmonary disease during treatment with moderate dose CR-theophylline. Eur J Clin Pharmacol 43 (1992) 125-129
96. Martin R.J., and Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis 145 (1992) 540-544
97. Olfson M., and Pincus H.A. Use of benzodiazepines in the community. Arch Intern Med 154 (1994) 1235-1240
98. Ohayon M.M., and Lader M.H. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63 (2002) 817-825
99. Zandstra S.M., Furer J.W., van de Lisdonk E.H., et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 37 (2002) 139-144
100. Holbrook A.M., Crowther R., Lotter A., Cheng C., and King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162 (2000) 225-233
101. Dundar Y., Dodd S., Strobl J., Boland A., Dickson R., and Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19 (2004) 305-322
102. Schneider H., Grote L., Peter J.H., Cassel W., and Guilleminault C. The effect of triazolam and flunitrazepam-two benzodiazepines with different half-lives-on breathing during sleep. Chest 109 (1996) 909-915
103. Reeves R.L. Comparison of triazolam, flurazepam, and placebo as hypnotics in geriatric patients with insomnia. J Clin Pharmacol 17 (1977) 319-323
104. Mitler M.M., Seidel W.F., van den Hoed J., Greenblatt D.J., and Dement W.C. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 4 (1984) 2-13
105. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 48 (1994) 25-40
106. Scharf M.B., Roth P.B., Dominguez R.A., and Ware J.C. Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia. J Clin Pharmacol 30 (1990) 461-467
107. Elie R., Ruther E., Farr I., Emilien G., and Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry 60 (1999) 536-544
108. Dooley M., and Plosker G.L. Zaleplon: a review of its use in the treatment of insomnia. Drugs 60 (2000) 413-445
109. Erman M.K., Erwin C.W., Gengo F.M., et al. Comparative efficacy of zolpidem and temazepam in transient insomnia. Hum Psychopharmacol 16 (2001) 169-176
110. Wadworth A.N., and McTavish D. Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 3 (1993) 441-459
111. Scharf M.B., Roth T., Vogel G.W., and Walsh J.K. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 55 (1994) 192-199
112. Krystal A.D., Walsh J.K., Laska E., et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26 (2003) 793-799
113. Glass J., Lanctot K.L., Herrmann N., Sproule B.A., and Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331 (2005) 1169
114. Nowell P.D., Mazumdar S., Buysse D.J., Dew M.A., Reynolds III C.F., and Kupfer D.J. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278 (1997) 2170-2177
115. Greene J.G., Pucino F., Carlson J.D., Storsved M., and Strommen G.L. Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study. Pharmacotherapy 9 (1989) 34-38
116. Woods J.H., and Winger G. Current benzodiazepine issues. Psychopharmacology 118 (1995) 107-115
117. Sorock G.S., and Shimkin E.E. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Intern Med 148 (1988) 2441-2444
118. Herings R.M., Stricker B.H., de Boer A., Bakker A., and Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 155 (1995) 1801-1807
119. Vergis E.N., Brennen C., Wagener M., and Muder R.R. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 161 (2001) 2378-2381
120. Camacho M.E., and Morin C.M. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 18 (1995) 644-645
121. Cohn M.A. The effects of brotizolam, a new hypnotic, on cardiac and respiratory function in volunteers. Respiration 45 (1984) 281-285
122. Beaupre A., Soucy R., Phillips R., and Bourgouin J. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration 54 (1988) 235-240
123. Maillard D., Thiercelin J.F., Fuseau E., Rosenzweig P., and Attali P. Effects of zolpidem versus diazepam and placebo on breathing control parameters in healthy human subjects. Int J Clin Pharmacol Res 12 (1992) 27-35
124. Mak K.H., Wang Y.T., Cheong T.H., and Poh S.C. The effect of oral midazolam and diazepam on respiration in normal subjects. Eur Respir J 6 (1993) 42-47
125. Ranlov P.J., and Nielsen S.P. Effect of zopiclone and diazepam on ventilatory response in normal human subjects. Sleep 10 Suppl. 1 (1987) 40-47
126. Wedzicha J.A., Wallis P.J., Ingram D.A., and Empey D.W. Effect of diazepam on sleep in patients with chronic airflow obstruction. Thorax 43 (1988) 729-730
127. Cohn M.A., Morris D.D., and Juan D. Effects of estazolam and flurazepam on cardiopulmonary function in patients with chronic obstructive pulmonary disease. Drug Saf 7 (1992) 152-158
128. Block A.J., Dolly F.R., and Slayton P.C. Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease?. Am Rev Respir Dis 129 (1984) 230-233
129. Cummiskey J., Guilleminault C., Del Rio G., and Silvestri R. The effects of flurazepam on sleep studies in patients with chronic obstructive pulmonary disease. Chest 84 (1983) 143-147
130. Dolly F.R., and Block A.J. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73 (1982) 239-243
131. Murciano D., Armengaud M.H., Cramer P.H., et al. Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J 6 (1993) 625-629
132. Murciano D., Aubier M., Palacios S., and Pariente R. Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD). Chest 97 (1990) 51S-52S
133. Midgren B., Hansson L., Skeidsvoll H., and Elmqvist D. The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. Chest 95 (1989) 765-768
134. Jolly E., Aguirre L., Jorge E., and Luna C. Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease. Medicina (B Aires) 56 (1996) 472-478
135. Rudolf M., Geddes D.M., Turner J.A., and Saunders K.B. Depression of central respiratory drive by nitrazepam. Thorax 33 (1978) 97-100
136. Berry R.B., McCasland C.R., and Light R.W. The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 146 (1992) 1256-1260
137. Steens R.D., Pouliot Z., Millar T.W., Kryger M.H., and George C.F. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 16 (1993) 318-326
138. Timms R.M., Dawson A., Hajdukovic R.M., and Mitler M.M. Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease. Arch Intern Med 148 (1988) 2159-2163
139. Beaumont M., Batejat D., Coste O., et al. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m. Neuropsychobiology 49 (2004) 154-162
140. Beaumont M., Goldenberg F., Lejeune D., Marotte H., Harf A., and Lofaso F. Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 m. Am J Respir Crit Care Med 153 (1996) 1864-1869
141. McCann C.C., Quera-Salva M.A., Boudet J., et al. Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects. Fundam Clin Pharmacol 7 (1993) 305-310
142. Cohn M.A. Effects of zolpidem, codeine phosphate and placebo on respiration. A double-blind, crossover study in volunteers. Drug Saf 9 (1993) 312-319
143. Girault C., Muir J.F., Mihaltan F., et al. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 110 (1996) 1203-1211
144. Muir J.F., DeFouilloy C., Broussier P., Locquet R., and Maillard F. Comparative study of the effects of zopiclone and placebo on respiratory function in patients with chronic obstructive respiratory insufficiency. Int Clin Psychopharmacol 5 Suppl. 2 (1990) 85-94
145. Erman M.K. Therapeutic options in the treatment of insomnia. J Clin Psychiatry 66 Suppl. 9 (2005) 18-23
146. Wagner J., Wagner M.L., and Hening W.A. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 32 (1998) 680-691
147. Lin C.C. Effects of protriptyline on day and night time oxygenation in patients with chronic obstructive pulmonary disease. J Formos Med Assoc 92 Suppl. 4 (1993) S232-S236
148. Series F., Cormier Y., and La Forge J. Changes in day and night time oxygenation with protriptyline in patients with chronic obstructive lung disease. Thorax 44 (1989) 275-279
149. Midgren B., Hansson L., Ahlmann S., and Elmqvist D. Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease. Respiration 57 (1990) 239-242